Suppr超能文献

牛嗜铬粒细胞膜中丁苯那嗪结合位点的光亲和标记

Photoaffinity labeling of the tetrabenazine binding sites of bovine chromaffin granule membranes.

作者信息

Isambert M F, Henry J P

出版信息

Biochemistry. 1985 Jul 2;24(14):3660-7. doi: 10.1021/bi00335a039.

Abstract

An azido derivative of tetrabenazine, a specific inhibitor of the monoamine carrier of chromaffin granule membranes, has been synthesized. In the dark, this compound, 3H-labeled N-(3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo [a]quinolizin-2-yl)-4-[(4-azido-2-nitrophenyl)amino]butanamide+ ++ ([3H]TBA), bound reversibly to purified chromaffin granule membranes. Centrifugation through SP-Sephadex columns was used to separate bound and free [3H]TBA. This technique gave low levels of nonspecific binding and allowed recovery of [3H]TBA-membrane complexes. Scatchard analysis of the data indicated one class of sites with an equilibrium dissociation constant KD of 50 nM and a density of sites of 40-50 pmol/mg of protein, consistent with reported densities of reserpine and dihydrotetrabenazine binding sites. Competition experiments showed that TBA and tetrabenazine bound to the same site. Irradiation at 435 nm of [3H]TBA-membrane mixtures induced some irreversible binding of the probe to membranes. After irreversible binding of TBA, the number of dihydrotetrabenazine binding sites was decreased, indicating that the probe was covalently bound to the monoamine carrier. [3H]TBA-membrane complexes isolated by centrifugation through SP-Sephadex columns were irradiated, and their radioactivity was analyzed by electrophoresis on sodium dodecyl sulfate/polyacrylamide gels. A polypeptide with a molecular weight of 70 000 was labeled. This polypeptide was different from dopamine beta-hydroxylase, and it was not adsorbed on concanavalin A-Sepharose. It is proposed that the monoamine carrier of chromaffin granule membrane has an oligomeric structure, involving a 45K subunit [Gabizon, R., Yetinson, T., & Schuldiner, S. (1982) J. Biol. Chem. 257, 15145] and a 70K subunit.

摘要

已合成了丁苯那嗪的叠氮衍生物,它是嗜铬粒细胞膜单胺载体的特异性抑制剂。在黑暗中,这种化合物,即3H标记的N-(3-异丁基-9,10-二甲氧基-1,2,3,4,6,7-六氢-11bH-苯并[a]喹嗪-2-基)-4-[(4-叠氮基-2-硝基苯基)氨基]丁酰胺([3H]TBA),与纯化的嗜铬粒细胞膜可逆结合。通过SP-葡聚糖凝胶柱离心来分离结合的和游离的[3H]TBA。该技术产生的非特异性结合水平较低,并能回收[3H]TBA-膜复合物。对数据进行Scatchard分析表明存在一类位点,其平衡解离常数KD为50 nM,位点密度为40 - 50 pmol/mg蛋白质,这与报道的利血平和二氢丁苯那嗪结合位点的密度一致。竞争实验表明TBA和丁苯那嗪结合到同一位点。用435 nm光照射[3H]TBA-膜混合物会诱导探针与膜发生一些不可逆结合。TBA发生不可逆结合后,二氢丁苯那嗪结合位点的数量减少,表明探针与单胺载体发生了共价结合。通过SP-葡聚糖凝胶柱离心分离得到的[

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验